Business Context and Reporting Period
This Form 8-K filing by Thermo Fisher Scientific Inc. (TMO) reports a material definitive agreement and other events related to a public debt offering. The report date is November 24, 2025, with the earliest event reported on December 1, 2025. The filing details the issuance of senior notes by Thermo Fisher Scientific (Finance I) B.V., a wholly-owned finance subsidiary, fully and unconditionally guaranteed by the parent company.
Key Financial Metrics and Transaction Details
The Company executed a public offering of two tranches of senior notes with an aggregate principal amount of €2.1 billion:
- Floating Rate Senior Notes due 2027: €1.0 billion aggregate principal amount.
- Fixed Rate Senior Notes due 2035: €1.1 billion aggregate principal amount with a coupon rate of 3.628%.
Proceeds and Use of Funds:
- Net Proceeds: Approximately €2.09 billion after deducting underwriting discounts and estimated offering expenses.
- Intended Use: General corporate purposes, including potential acquisitions, debt repayment/refinancing, working capital, capital expenditures, or equity repurchases. Funds may be temporarily invested in short-term, liquid investments.
Debt Structure and Covenants:
- The Notes are general unsecured obligations of the subsidiary and rank equally with existing unsecured indebtedness.
- The Notes are structurally subordinated to the indebtedness of other subsidiaries.
- Covenants: Limited negative covenants restrict liens on Principal Properties, sale and lease-back transactions regarding Principal Properties, and mergers or asset sales.
- Change of Control: Requires an offer to purchase the Notes at 101% of principal plus accrued interest if a change of control occurs alongside a downgrade below investment grade by at least two major rating agencies.
Material Changes Versus Prior Period
This filing represents a new issuance of debt rather than a comparative financial performance report. Consequently, there are no revenue, profit, or cash flow changes versus a prior comparable period disclosed in this specific document. The primary material change is the increase in the Company's outstanding debt obligations by €2.1 billion in principal.
Guidance, Outlook, and Risks
Management Commentary: Management intends to utilize the net proceeds for flexible general corporate purposes, signaling a strategy to maintain liquidity for strategic opportunities such as acquisitions or share repurchases.
Risks and Contingencies:
- Interest Rate Risk: The Floating Rate Notes expose the Company to variable interest rate fluctuations until maturity in 2027.
- Call Provisions: The Fixed Rate Notes (2035) are subject to redemption prior to September 1, 2035, at a price equal to the greater of 100% of principal or the present value of remaining payments (make-whole provision). After the Par Call Date, they may be redeemed at 100% of principal.
- Default Risks: Events of default include payment defaults, covenant breaches, bankruptcy, and failure to pay certain other indebtedness, which could trigger acceleration of the entire principal amount.
Important Facts for Investor Verification
- Verify the exact closing date and final interest rate calculations for the Floating Rate Notes, as they are subject to quarterly adjustments.
- Confirm the specific allocation of the €2.09 billion net proceeds in subsequent quarterly reports to determine if funds were used for debt refinancing, acquisitions, or buybacks.
- Monitor the Company's credit ratings from Moody's, S&P, and Fitch to assess the risk of triggering the change of control repurchase provision.
- Review the "Principal Properties" definition in the Indenture (Exhibit 4.2) to understand the scope of restrictions on future secured borrowing.